PROGENTEC DIAGNOSTICS

Serial Number 88258685
Registration 6005176
700

Registration Progress

Application Filed
Jan 11, 2019
Under Examination
Approved for Publication
Dec 24, 2019
Published for Opposition
Dec 24, 2019
Registered
Mar 10, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200310)
Due: Mar 10, 2026 73 days

Trademark Image

PROGENTEC DIAGNOSTICS

Basic Information

Serial Number
88258685
Registration Number
6005176
Filing Date
January 11, 2019
Registration Date
March 10, 2020
Published for Opposition
December 24, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 10, 2020
Registration
Registered
Classes
035 038 042

Rights Holder

Progentec Diagnostics, Inc.

03
Address
Suite MC 302.4 OMRF, Building
825 N.E. 13th Street
Oklahoma City, OK 73104

Ownership History

Progentec Diagnostics, Inc.

Original Applicant
03
Oklahoma City, OK

Progentec Diagnostics, Inc.

Owner at Publication
03
Oklahoma City, OK

Progentec Diagnostics, Inc.

Original Registrant
03
Oklahoma City, OK

Legal Representation

Attorney
Edwin Flores

USPTO Deadlines

Next Deadline
73 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200310)
Due Date
March 10, 2026
Grace Period Ends
September 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Mar 10, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 10, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 24, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 24, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 18, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 18, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 18, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 18, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 18, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 7, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 7, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 7, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 25, 2019 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Apr 23, 2019 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Apr 3, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 13, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 13, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 13, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 13, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 13, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 5, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 2, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 15, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting and management in the field of clinical trials, namely, patient enrollment tracking and monitoring, pharmaceutical and medicine tracking; business consulting and management in the field of clinical trials, namely, compilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trials, namely, clinical data management; marketing consulting, namely, designing and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticals, biologics, diagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocols, take part in clinical studies and recruit patients to take part in clinical studies; promoting public awareness of the need for improved prevention and treatment of illnesses, and for improved health care quality and efficiency; public advocacy to promote awareness of the need for assuring patients safe access to affordable medicine; promoting technical and scientific investigation, research, and experimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticals, diagnostic tools, biomarkers and medical devices; and public advocacy to promote awareness of scientific, research and medical advances
First Use Anywhere: Jan 11, 2019
First Use in Commerce: Jan 11, 2019
Class 038
Providing access to a computer database; providing on-line forums for transmission of messages among computer and mobile device users concerning patient, doctor and caregiver information in order to generate, manage and share medical information; and provision of access to databases
First Use Anywhere: Jan 11, 2019
First Use in Commerce: Jan 11, 2019
Class 042
Medical and scientific research and development in the field of medicine, the prevention, treatment, management of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical tools, preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating thereto, namely, scientific analysis in the fields of pharmaceutical and medical device /diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products/services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; and working on and evaluation of biomarkers and diagnostic products; and providing an online network service that enables users to share data in the field of healthcare; non-downloadable computer software provided via the Internet as an Application Service Provider ASP-hosted solution for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information
First Use Anywhere: Jan 11, 2019
First Use in Commerce: Jan 11, 2019

Additional Information

Translation
The wording "progentec" has no meaning in a foreign language.

Classification

International Classes
035 038 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DIAGNOSTICS"